DISA's continuous driver monitoring helps employers differentiate a good driver from a bad driver, while also reducing administrative burden, crashes, and cost over time.
Despite common misconceptions, collection sites are a safe place to send your employees to continue your company's drug testing program during the COVID-19 pandemic.
Substance abuse has been known to increase in times of a national crisis. It's important for employers to enhance their drug testing programs to ensure safety in the workplace during and following the COVID-19 pandemic.
Antibody testing helps employers gain a better understanding of the coronavirus and its transmission as employees reenter the workforce.
The CDC has issued guidelines for CMV drivers and employers to follow to remain safe during COVID-19.